Rhythm Pharmaceuticals (RYTM) had the highest return between June 1, 2022 and July 30, 2022 by a mid-cap US stock, returning 262.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 7/30/2022 | 262.07% |
Pagaya Technologies (PGY) | 6/1/2022 - 7/30/2022 | 149.45% |
Belite Bio Inc ADR (BLTE) | 6/1/2022 - 7/30/2022 | 121.78% |
New Oriental Education & Technology (EDU) | 6/1/2022 - 7/30/2022 | 109.24% |
Impinj (PI) | 6/1/2022 - 7/30/2022 | 78.31% |
Arcellx (ACLX) | 6/1/2022 - 7/30/2022 | 73.62% |
Nuvalent (NUVL) | 6/1/2022 - 7/30/2022 | 66.97% |
Wingstop (WING) | 6/1/2022 - 7/30/2022 | 57.73% |
Hims Hers Health (HIMS) | 6/1/2022 - 7/30/2022 | 53.6% |
Privia Health (PRVA) | 6/1/2022 - 7/30/2022 | 53.25% |
Axsome Therapeutics (AXSM) | 6/1/2022 - 7/30/2022 | 52.83% |
Calix (CALX) | 6/1/2022 - 7/30/2022 | 52.39% |
Enphase Energy (ENPH) | 6/1/2022 - 7/30/2022 | 51.39% |
Veracyte (VCYT) | 6/1/2022 - 7/30/2022 | 48.31% |
PTC Therapeutics (PTCT) | 6/1/2022 - 7/30/2022 | 48.23% |
Kymera Therapeutics (KYMR) | 6/1/2022 - 7/30/2022 | 45.6% |
Gitlab (GTLB) | 6/1/2022 - 7/30/2022 | 45.17% |
Nuscale Power (SMR) | 6/1/2022 - 7/30/2022 | 44.63% |
Ocular Therapeutix (OCUL) | 6/1/2022 - 7/30/2022 | 42.22% |
Catalyst Pharmaceuticals (CPRX) | 6/1/2022 - 7/30/2022 | 41.24% |
Denali Therapeutics (DNLI) | 6/1/2022 - 7/30/2022 | 39.77% |
TransMedics (TMDX) | 6/1/2022 - 7/30/2022 | 38.19% |
TG Therapeutics (TGTX) | 6/1/2022 - 7/30/2022 | 38.02% |
Recursion Pharmaceuticals (RXRX) | 6/1/2022 - 7/30/2022 | 38.01% |
Alignment Healthcare LLC (ALHC) | 6/1/2022 - 7/30/2022 | 37.07% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
